Am I anxious?

The GAD-7 measures generalised anxiety disorder (GAD). It's quick and easy to use, previous results will be displayed on this page for your next visit. Simply click 'Clear Results' to remove your data. To start, 'click' on the most appropriate answer alongside each question.

Over the last two weeks, how often have you been bothered by any of the following
1. Feeling nervous, anxious or on edge?
2. Not being able to stop or control worrying?
3. Worrying too much about different things?
4. Trouble relaxing?
5. Being so restless that it is hard to sit still?
6. Becoming easily annoyed or irritable?
7. Feeling afraid as if something awful might happen?
The GAD-7

Confidentiality

Your results are confidential. This page doesn't collect, save or transmit any personal information.

Scoring the GAD-7

Anxiety severity is calculated by assigning scores of 0, 1, 2, and 3 to the categories of 'not at all'; 'several days'; 'more than half the days' and 'nearly every day' respectively. The total score for the seven items ranges from 0 to 21.


Scores of 5, 10, and 15 are cut-off points for mild, moderate, and severe anxiety, respectively


Using the threshold score of 10, the GAD‐7 has a sensitivity of 89% and a specificity of 82% for generalised anxiety disorder (GAD). It is moderately good at screening three other common anxiety disorders - panic disorder (sensitivity 74%, specificity 81%), social anxiety disorder (sensitivity 72%, specificity 80%), and post-traumatic stress disorder (PTSD) (sensitivity 66%, specificity 81%). The sum of the first two questions is sometimes used as a quick guide to the presence of anxiety. The 'GAD-2' as this is called, gives a score between zero and six. A score of three or more warrants further investigation.


When screening for anxiety disorders, a recommended cut-off point for further evaluation is a score of ten or more. A diagnosis can't be made using the GAD-7 alone; a professional clinical interview should consider the possibility of physical causes, drug use and any manic / hypomanic episodes.


Copies of the PHQ and GAD-7 are available from the PHQ Screeners website. From the Primary Care Evaluation of Mental Disorders Patient Health Questionnaire (PRIME-MD PHQ). The GAD-7 was developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues. PRIME-MD is a trademark of Pfizer Inc. Copyright 1999 Pfizer Inc. All rights reserved.


Spitzer, R.L., Kroenke, K., Williams, J.B.W., Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine 166 p.1092-1097.


Disclaimer

Disclaimer

Although the GAD-7 is a well-researched measure of anxiety, this page is for information only. Nothing here is a substitute for professional advice, diagnosis or treatment.


Please don't discontinue treatment, disregard medical advice or delay seeking advice because of something you have found on the internet, either on this site or elsewhere.


If you are concerned about your results, please seek the advice of a qualified health professional.


0%
Made with in North Wales on 29 October, 2017 - it's currently
image-1 image-2 image-3 image-4 image-5 image-6 image-7 image-8